• 1
    Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A. Obesity and renal cell cancer-a quantitative review. Br J Cancer 2001; 85: 984990
  • 2
    Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343: 13051311
  • 3
    Wulaningsih W, Garmo H, Holmberg L et al. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study. J Cancer Epidemiol 2012; 2012: 792034
  • 4
    Inoue M, Noda M, Kurahashi N et al. Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur J Cancer Prev 2009; 18: 240247
  • 5
    Magura L, Blanchard R, Hope B, Beal JR, Schwartz GG, Sahmoun AE. Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control 2008; 19: 12591266
  • 6
    Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol 2008; 18: 671677
  • 7
    Lim U, Gayles T, Katki HA et al. Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma. Cancer Res 2007; 67: 55695574
  • 8
    Khurana V, Caldito G, Ankem M. Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. Urology 2008; 71: 118122
  • 9
    Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, Hayakawa M. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 2008; 38: 106111
  • 10
    Van Hemelrijck M, Garmo H, Hammar N et al. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int J Cancer 2012; 130: 21182128
  • 11
    Ahn J, Lim U, Weinstein SJ et al. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 28142821
  • 12
    Wang G, Hou J, Ma L et al. Risk factor for clear cell renal cell carcinoma in Chinese population: a case-control study. Cancer Epidemiol 2012; 36: 177182
  • 13
    Freeman MR, Solomon KR. Cholesterol and benign prostate disease. Differentiation 2011; 82: 244252
  • 14
    Kitahara CM, Berrington de Gonzalez A, Freedman ND et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 2011; 29: 15921598
  • 15
    Ulmer H, Borena W, Rapp K et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer 2009; 101: 12021206
  • 16
    Haggstrom C, Rapp K, Stocks T et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS One 2013; 8: e57475
  • 17
    Zhang C, Yu L, Xu T et al. Association of dyslipidemia with renal cell carcinoma: a 1ratio2 matched case-control study. PLoS One 2013; 8: e59796
  • 18
    Qian Y, Pu Y, Liu L et al. Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study. PLoS One 2013; 8: e64395
  • 19
    Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 2007; 31: 177188
  • 20
    WHO maps noncommunicable disease trends in all countries: country profiles on noncommunicable disease trends in 193 countries. Cent Eur J Public Health 2011; 19: 130, 138
  • 21
    Knight TM, Smith Z, Whittles A et al. Insulin resistance, diabetes, and risk markers for ischaemic heart disease in Asian men and non-Asian in Bradford. Br Heart J 1992; 67: 343350
  • 22
    Dumitrescu L, Carty CL, Taylor K et al. Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet 2011; 7: e1002138
  • 23
    Elbers CC, Guo Y, Tragante V et al. Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. PLoS One 2012; 7: e50198
  • 24
    Zhao WH, Zhang J, You Y et al. Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China. Chin J Prev Med 2005; 39: 306310
  • 25
    Yang W, Zhao W, Xiao J et al. Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One 2012; 7: e39513
  • 26
    Jiang LX, Li X, Li J et al. A cross-sectional study on the use of statin among patients with atherosclerotic ischemic stroke in China. Chin J Epidemiol 2010; 31: 925928